0001209191-20-010554.txt : 20200219
0001209191-20-010554.hdr.sgml : 20200219
20200219163851
ACCESSION NUMBER: 0001209191-20-010554
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20200217
FILED AS OF DATE: 20200219
DATE AS OF CHANGE: 20200219
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Silva Paul M
CENTRAL INDEX KEY: 0001446372
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 000-19319
FILM NUMBER: 20630381
MAIL ADDRESS:
STREET 1: C/O VERTEX PHARMACEUTICALS INCORPORATED
STREET 2: 130 WAVERLY ST
CITY: CAMBRIDGE
STATE: MA
ZIP: 02139
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: VERTEX PHARMACEUTICALS INC / MA
CENTRAL INDEX KEY: 0000875320
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 043039129
STATE OF INCORPORATION: MA
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 50 NORTHERN AVENUE
CITY: BOSTON
STATE: MA
ZIP: 02210
BUSINESS PHONE: 6173416393
MAIL ADDRESS:
STREET 1: 50 NORTHERN AVENUE
CITY: BOSTON
STATE: MA
ZIP: 02210
4
1
doc4.xml
FORM 4 SUBMISSION
X0306
4
2020-02-17
0
0000875320
VERTEX PHARMACEUTICALS INC / MA
VRTX
0001446372
Silva Paul M
C/O VERTEX PHARMACEUTICALS INCORPORATED
50 NORTHERN AVENUE
BOSTON
MA
02210
0
1
0
0
SVP & Controller
Common Stock
2020-02-17
4
F
0
1248
241.50
D
18440
D
Common Stock
2020-02-18
4
S
0
240
241.95
D
18200
D
Common Stock
2020-02-18
4
S
0
640
242.80
D
17560
D
Common Stock
2020-02-18
4
S
0
202
243.85
D
17358
D
Common Stock
2020-02-18
4
S
0
280
245.00
D
17078
D
Common Stock
2020-02-18
4
S
0
202
245.74
D
16876
D
Common Stock
169
I
401(k)
Transaction made pursuant to Mr. Silva's company approved trading plan under Rule 10b5-1.
Open market sales reported on this line occurred at a weighted average price of $241.95 (range $241.43 to $242.40).
Mr. Silva undertakes to provide (upon request by the SEC staff, the issuer or a security holder of the issuer) full information regarding the number of shares sold at each separate price.
Open market sales reported on this line occurred at a weighted average price of $242.80 (range $242.45 to $243.32).
Open market sales reported on this line occurred at a weighted average price of $243.85 (range $243.52 to $244.29).
Open market sales reported on this line occurred at a weighted average price of $245.00 (range $244.52 to $245.43.)
Open market sales reported on this line occurred at a weighted average price of $245.74 (range $245.55 to $245.86.)
/s/ Omar White, Attorney-in-Fact
2020-02-19